Pilot study of Sirolimus (rapamycin) as primary immunosuppression following liver transplantation.

被引：0
|
作者：
Crosbie, OM [1 ]
Collier, J [1 ]
Bateman, E [1 ]
Watson, CJ [1 ]
Calne, R [1 ]
Gimson, AE [1 ]
Alexander, GJ [1 ]
机构：
[1] Univ Cambridge, Sch Clin Med, Cambridge, England
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
100
引用
收藏
页码：185A / 185A
页数：1
相关论文
共 50 条
  • [21] Thrombocytopenia following liver transplantation.
    Chatzipetrou, MA
    Weppler, D
    Tsaroucha, A
    Iaria, G
    Lupo, F
    Kenyon, NS
    Ricordi, C
    Tzakis, AG
    GASTROENTEROLOGY, 1998, 114 (04) : A1224 - A1224
  • [22] Biomarkers of Immunosuppression in Liver Transplantation (LT): A Pilot Study.
    Mukerji, Amar N.
    Geier, Steven
    Parekh, Hemant
    Potula, Raghava
    Karachristos, Andreas
    Maloo, Manoj
    Jain, Ashokkumar
    LIVER TRANSPLANTATION, 2013, 19 : S310 - S311
  • [23] Optimal timing for conversion to sirolimus after liver transplantation.
    Frank, AM
    Timmins, KJ
    Abt, PL
    Markmann, JF
    Olthoff, KM
    Shaked, A
    HEPATOLOGY, 2004, 40 (04) : 558A - 558A
  • [24] Steroid Free, Tacrolimus Once Daily Based Immunosuppression Following Orthotopic Liver Transplantation.
    Moench, Christian
    Ulrich, Frank
    Hofmann, Wolf P.
    Sarrazin, Christoph
    Zeuzem, Stefan
    Bechstein, Wolf O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 533 - 533
  • [25] Impact of Rapamycin on HCV Recurrence after Liver Transplantation.
    Johnson, M.
    Sellers, M.
    Bruno, C.
    Kegley, K.
    Tan, M.
    Pollinger, H.
    Galambos, M.
    Cross, R.
    Jones, J.
    Sutton, P.
    Rubin, R.
    Shrestha, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 528 - 528
  • [26] Successful Immunosuppression With Sirolimus in Liver Transplantation. Long Term Follow-Up, a One Center Experience.
    Munoz, Linda E.
    Cordero, Paula
    Silvera, Ana
    Gonzalez, Alfonso
    Sanchez, Concepcion
    Perez, Edelmiro
    Zapata, Homero
    Escobedo, Miguel
    LIVER TRANSPLANTATION, 2014, 20 : S247 - S247
  • [27] Azathioprine Immunosuppression Is Protective Against Recurrence of Primary Biliary Cirrhosis after Liver Transplantation.
    Saffioti, Francesca
    Manousou, Pinelopi
    Parisi, Ioanna
    Tsochatzis, Emmanuel
    Theocharidou, Eleni
    Dhillon, Amar P.
    Tu Vinh Luong
    Patch, David
    O'Beirne, James
    Thorburn, Douglas
    Pinzani, Massimo
    Burroughs, Andrew K.
    LIVER TRANSPLANTATION, 2014, 20 : S247 - S247
  • [28] Reliable Steroid-Free Immunosuppression in Liver Transplantation.
    Lupo, Luigi G.
    Notarnicola, Rosamaria
    Valentini, Maria F.
    Roselli, Stefania
    Poli, Elisabetta
    Scilandrone, Grazisa
    Panzera, Piercarmine
    Memeo, Vincenzo
    LIVER TRANSPLANTATION, 2013, 19 : S268 - S269
  • [29] Personalizing Immunosuppression with Molecular Phenotyping in Pediatric Liver Transplantation.
    Ningappa, M.
    Ashokkumar, C.
    Sun, Q.
    Higgs, B.
    Soltys, K.
    Bond, G.
    Mazariegos, G.
    Sindhi, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 233 - 233
  • [30] Immunosuppression withdrawal following liver transplantation
    Whitehouse, Gavin P.
    Sanchez-Fueyo, Alberto
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2014, 38 (06) : 676 - 680
12345